Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 10 out of 212Page size: 10
Sort by: 1st author
  1. Published

    Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow-up

    Abrahamsson, H., Jensen, B. V., Berven, L. L., Nielsen, D. L., Šaltytė Benth, J., Johansen, J. S., Larsen, F. O., Johansen, Julia Sidenius & Ree, A. H., Apr 2020, In: International Journal of Cancer. 146, 7, p. 2019-2026

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Regional and age differences in specialised palliative care for patients with pancreatic cancer

    Adsersen, M., Chen, I. M., Rasmussen, L. S., Johansen, Julia Sidenius, Nissen, M., Grønvold, Mogens & Marsaa, K., 2021, In: BMC Palliative Care. 20, 1, 9 p., 192.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population

    Allin, K. H., Bojesen, Stig Egil, Johansen, Julia Sidenius & Nordestgaard, Børge, 3 Jan 2012, In: B J C. 106, 1, p. 199-205 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients

    Ammitzbøll, C. G., Steffensen, R., Bøgsted, M., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, Julia Sidenius, Pødenphant, J., Østergaard, Mikkel, Ellingsen, T. & Stengaard-Pedersen, K., 2014, In: Arthritis Research & Therapy (Print). 16, 5, p. 1-8 8 p., 475.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    M-ficolin, an activator of the complement system, predicts DAS28 remission in early DMARD naïve rheumatoid arthritis.

    Ammizbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, Julia Sidenius, Østergaard, Mikkel, Pødenphant, J., Stengaard-Pedersen, K. & OPERA study group, O. S. G., 2012, In: Scandinavian Journal of Rheumatology. Supplement. 41, 126 suppl., p. 24 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  6. Published

    M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.

    Ammizbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, Julia Sidenius, Østergaard, Mikkel, Pødenphant, J. & Stengaard-Pedersen, K., 2012, In: Arthritis & Rheumatism. 64, 10, p. S1065 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  7. Published

    Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer

    Andersen, H. H., Bojesen, Stig Egil, Johansen, Julia Sidenius, Ejlertsen, Bent Laursen, Berg, T., Tuxen, M., Madsen, K., Danø, H., Flyger, H., Jensen, M. B. & Nielsen, Dorte Lisbet, 2024, In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 33, 5, p. 662-670 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Exercise in older women with breast cancer during systemic therapy: Study protocol of a randomised controlled trial (BREACE)

    Andersen, H. H., Mikkelsen, M. K., Lundager, I., Lund, Cecilia Margareta, Johansen, Julia Sidenius, Vinther, A., Bogh Juhl, C., Zerahn, B., Ragle, A. M. & Nielsen, Dorte Lisbet, 2020, In: BMJ Open. 10, 10, 8 p., e038674.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

    Axelsen, M. B., Eshed, I., Hørslev-Petersen, K., Stengaard-Pedersen, K., Hetland, M. L., Møller, J., Junker, P., Pødenphanth, J., Schlemmer, A., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Dam, M. Y., Hansen, I., Horn, H. C., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J. & 4 others, Krogh, N. S., Johansen, Julia Sidenius, Østergaard, Mikkel & OPERA study group, O. S. G., May 2015, In: Annals of the Rheumatic Diseases. 74, 5, p. 867-875 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Prognostic impact of Charlson’s Age-Comorbidity Index and other risk factors in patients with pancreatic cancer

    Bagni, K., Chen, I. M., Johansen, A. Z., Dehlendorff, C., Jensen, B. V., Hansen, C. P., Hasselby, Jane Preuss, Holländer, N. H., Nissen, M., Bjerregaard, J. K., Pfeiffer, P., Yilmaz, M. K., Rasmussen, L. S., Nielsen, S. E. & Johansen, Julia Sidenius, May 2020, In: European Journal of Cancer Care. 29, 3, 12 p., e13219.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...22 Next

ID: 13762833